Monday, July 14, 2014

Adam Feuerstein responds to my question regarding Mannkind's Alfrezza label

He provides a detailed response to my question on today's article.

I continue to be neutral on Mannkind between their lack of partnership, label, and financial weakness. 

No comments:

Post a Comment

Thank you for your contribution to BiotechInvestor.com